Assessment of psoriatic arthritis
An overview of low disease activity and remission in psoriatic arthritis
E. Lubrano1, F.M. Perrotta2, A. Kavanaugh3
- Academic Rheumatology Unit, Department of Medicine and Health Science “Vincenzo Tiberio”, University of Molise, Italy. enniolubrano@hotmail.com
- Academic Rheumatology Unit, Department of Medicine and Health Science “Vincenzo Tiberio”, University of Molise, Italy.
- Division of Rheumatology, Allergy, and Immunology Center for Innovative Therapy (CIT), University of California, San Diego, La Jolla, CA, USA.
CER8865
2015 Vol.33, N°5 ,Suppl.93
PI 0051, PF 0054
Assessment of psoriatic arthritis
Free to view
(click on article PDF icon to read the article)
PMID: 26470835 [PubMed]
Received: 13/08/2015
Accepted : 20/08/2015
In Press: 15/10/2015
Published: 16/10/2015
Abstract
Psoriatic arthritis (PsA) is a complex, multisystem and potentially disabling disease with musculoskeletal and skin manifestations. In PsA, as well as in the other chronic rheumatic conditions, a state of low disease activity or remission should be the target of treatment but to reach this objective, in the assessment of PsA patients, is still an unmet need due to the heterogeneity of disease manifestations. With the introduction of anti-TNF treatment, low disease activity or remission become an achievable and suitable state that could be reached by 50%–60% of PsA patients. The aim of this paper is to briefly summarise the concept of low disease activity and remission in PsA, with particular focus on anti-TNF therapy.
